Clinical Trials Directory

Trials / Completed

CompletedNCT03060616

Validation of Hemorrhoidal Bleeding Score

Status
Completed
Phase
Study type
Observational
Enrollment
130 (actual)
Sponsor
Fondation Hôpital Saint-Joseph · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The principal manifestation of hemorrhoidal disease is bleeding; however the severity evaluation is today based on prolapsus (Goligher classification) and bleeding factor is not included. Even if there was some rare score including bleeding in literature , none of them were validated. The aim of the study is first validation of bleeding score .

Conditions

Timeline

Start date
2016-09-01
Primary completion
2018-03-15
Completion
2018-03-15
First posted
2017-02-23
Last updated
2023-04-27

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT03060616. Inclusion in this directory is not an endorsement.